About this trial
Comparative evaluation of cross-linked collagen membrane with and without silk fibroin around Immediate Dental Implants -Randomized controlled trial.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Systemically healthy patients in the age group of 18 to 55years.
Patients undergoing immediate implant placement with gingival thickness ≤ 1mm
Stage II /Stage III and Grade B Periodontitis patients.
Radiographic assessment using Radiovisiography (RVG) with grid.
Disqualifiers
Patients having allergies with collagen and silk products.
Medical conditions contraindicating surgical interventions.
Known smokers and alcoholic.
Acute infections at the site of extraction. Ex Abscess.
Trial design
Parallel
Treatments tested in this trial
collagen with silk fibroin membrane
Other interventionA mucoperiosteal flap will be raised and atraumatic extraction will be done. An immediate implant with collagen with silk fibroin membrane (experimental group) will be placed according to the standard protocol. An immediate implant with collagen membrane ( comparative group) will be placed according to the standard protocol . The surgical wound closure will be coapted with mattress and single interrupted sutures
cross linked collagen membrane
Other interventionA mucoperiosteal flap will be raised and atraumatic extraction will be done. An immediate implant with collagen with silk fibroin membrane (experimental group) will be placed according to the standard protocol.
Treatment groups
Trial outcomes
Primary outcomes
To assess wound healing, gingival thickness and keratinized tissue width
Gingival tissue thickness assessment will be done at the site of implant placement 1.5 mm below the gingival margin of adjacent tooth. Local anaesthesia will be administered before the procedure and an Endodontic K-file with silicone disc stop will be used to measure. The depth will be measured with UNC-15 probe. Apico-coronal width of keratinized tissue is measured as the distance from the mucogingival junction to the gingival margin, with the mucogingival junction determined using Schiller's Potassium Iodide Solution.
Secondary outcomes
Radiovisiography with grid
assess increase in bone volume
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: